Kalshi to allow bets on clinical trials, FDA decisions

Article content is unavailable (HTTP 403), so no financial news, numbers, or actionable market information could be extracted.

Analysis

Article content is unavailable (HTTP 403), so no financial news, numbers, or actionable market information could be extracted.

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Overall Sentiment

neutral

Sentiment Score

0.00